Entry,Entry name,Status,Protein names,Gene names,Organism,Gene ontology (biological process),Gene ontology (GO),Gene ontology IDs
P10160,IF5A1_RABIT,reviewed,Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D),EIF5A,Oryctolagus cuniculus (Rabbit),mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031],GO:0003746; GO:0005643; GO:0005789; GO:0015031; GO:0043022; GO:0045727; GO:0045901; GO:0045905; GO:0051028
Q62717,CAPS1_RAT,reviewed,Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1) (rCAPS),Cadps Caps Caps1,Rattus norvegicus (Rat),catecholamine secretion [GO:0050432]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle priming [GO:0016082]; vesicle organization [GO:0016050],"cytoplasmic vesicle [GO:0031410]; dense core granule [GO:0031045]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; catecholamine secretion [GO:0050432]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle priming [GO:0016082]; vesicle organization [GO:0016050]",GO:0005509; GO:0005546; GO:0006887; GO:0015031; GO:0016050; GO:0016082; GO:0019901; GO:0031045; GO:0031410; GO:0045055; GO:0045921; GO:0045956; GO:0050432; GO:0098674; GO:0098793; GO:0098978; GO:0099525
A2AJ76,HMCN2_MOUSE,reviewed,Hemicentin-2,Hmcn2,Mus musculus (Mouse),response to stimulus [GO:0050896],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896],GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023
Q9BYK8,HELZ2_HUMAN,reviewed,"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)",HELZ2 KIAA1769 PRIC285,Homo sapiens (Human),"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]",GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0019216; GO:0030374; GO:0045944; GO:0046872
Q24400,MLP2_DROME,reviewed,Muscle LIM protein Mlp84B,Mlp84B LIM3 CG1019,Drosophila melanogaster (Fruit fly),actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214],GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0045214; GO:0046872; GO:0060537
Q96WM9,LAC2_BOTFU,reviewed,Laccase-2 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 2) (Diphenol oxidase 2) (Urishiol oxidase 2),lcc2,Botryotinia fuckeliana (Noble rot fungus) (Botrytis cinerea),lignin catabolic process [GO:0046274],extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274],GO:0005507; GO:0005576; GO:0046274; GO:0052716
P97864,CASP7_MOUSE,reviewed,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],Casp7 Lice2 Mch3,Mus musculus (Mouse),aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0043231; GO:0051146; GO:0051402; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097200
P00178,CP2B4_RABIT,reviewed,Cytochrome P450 2B4 (EC 1.14.14.1) (CYPIIB4) (Cytochrome P450 isozyme 2) (Cytochrome P450 LM2) (Cytochrome P450 type B0) (Cytochrome P450 type B1),CYP2B4,Oryctolagus cuniculus (Rabbit),,endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0005506; GO:0005789; GO:0020037; GO:0070330
Q02858,TIE2_MOUSE,reviewed,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b),Tek Hyk Tie-2 Tie2,Mus musculus (Mouse),angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570],GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001934; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007169; GO:0007275; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016021; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0033138; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043552; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0046777; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000251; GO:2000352
Q54KA7,SECG_DICDI,reviewed,"Ankyrin repeat, PH and SEC7 domain containing protein secG",secG DDB_G0287459,Dictyostelium discoideum (Slime mold),actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012],cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012],GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327
Q62725,NFYC_RAT,reviewed,Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (CCAAT-binding transcription factor subunit C) (CBF-C) (Nuclear transcription factor Y subunit C) (NF-YC),Nfyc,Rattus norvegicus (Rat),"positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]","CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]",GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006366; GO:0008134; GO:0016602; GO:0032993; GO:0045893; GO:0045944; GO:0046982; GO:0090575
Q6NT55,CP4FN_HUMAN,reviewed,Cytochrome P450 4F22 (EC 1.14.14.-),CYP4F22,Homo sapiens (Human),ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690],"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690]",GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016021; GO:0016705; GO:0020037; GO:0046513
Q9Z2J0,S23A1_MOUSE,reviewed,Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3),Slc23a1 Svct1 Yspl3,Mus musculus (Mouse),brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904],GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070904
P08953,TOLL_DROME,reviewed,Protein toll (EC 3.2.2.6),Tl CG5490,Drosophila melanogaster (Fruit fly),antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]; Toll signaling pathway [GO:0008063],"cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; virion binding [GO:0046790]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]",GO:0002224; GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009597; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0035212; GO:0038023; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046790; GO:0050135; GO:0050830; GO:0061760; GO:0061809; GO:0070976; GO:1902875
O42127,FGFR3_XENLA,reviewed,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1),fgfr3,Xenopus laevis (African clawed frog),apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284],GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0016021
A3R064,DOK3_CHICK,reviewed,Docking protein 3 (Downstream of tyrosine kinase 3),DOK3,Gallus gallus (Chicken),,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],GO:0005737; GO:0005886
Q5R4M8,P5CS_PONAB,reviewed,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],ALDH18A1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0019240; GO:0055129
P86854,PLCL_MYTGA,reviewed,Perlucin-like protein,,Mytilus galloprovincialis (Mediterranean mussel),,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246
Q93YS4,AB22G_ARATH,reviewed,ABC transporter G family member 22 (ABC transporter ABCG.22) (AtABCG22) (White-brown complex homolog protein 23) (AtWBC23),ABCG22 WBC23 At5g06530 F15M7.6,Arabidopsis thaliana (Mouse-ear cress),response to water deprivation [GO:0009414]; transpiration [GO:0010148],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to water deprivation [GO:0009414]; transpiration [GO:0010148],GO:0005524; GO:0005886; GO:0009414; GO:0010148; GO:0016021; GO:0016887
P48035,FABP4_BOVIN,reviewed,"Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (A-FABP) (AFABP) (Fatty acid-binding protein 4)",FABP4,Bos taurus (Bovine),"brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cholesterol homeostasis [GO:0042632]; cytokine production [GO:0001816]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; white fat cell differentiation [GO:0050872]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cholesterol homeostasis [GO:0042632]; cytokine production [GO:0001816]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; white fat cell differentiation [GO:0050872]",GO:0001816; GO:0005324; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006631; GO:0008284; GO:0010628; GO:0010629; GO:0015909; GO:0036041; GO:0042632; GO:0045892; GO:0050729; GO:0050872; GO:0050873; GO:0071285
P08842,STS_HUMAN,reviewed,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),STS ARSC1,Homo sapiens (Human),epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706],GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872
Q6AYS4,FUCO2_RAT,reviewed,Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2),Fuca2,Rattus norvegicus (Rat),carbohydrate metabolic process [GO:0005975]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; carbohydrate metabolic process [GO:0005975]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],GO:0004560; GO:0005615; GO:0005764; GO:0005975; GO:0006004; GO:0009617; GO:0016139; GO:2000535
Q0IIF9,CP2U1_BOVIN,reviewed,Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),CYP2U1,Bos taurus (Bovine),,"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",GO:0005506; GO:0005743; GO:0005789; GO:0016021; GO:0016712; GO:0020037; GO:0102033
P62840,UB2D2_XENLA,reviewed,Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein 4) (xUBC4) (Ubiquitin carrier protein D2) (Ubiquitin-protein ligase D2),ube2d2 ubc4 ube2d3.1,Xenopus laevis (African clawed frog),,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0005524; GO:0061631
Q3UMF9,FAXC_MOUSE,reviewed,Failed axon connections homolog,Faxc,Mus musculus (Mouse),,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021],GO:0005737; GO:0016021
P24470,CP2CN_RAT,reviewed,Cytochrome P450 2C23 (EC 1.14.14.-) (Arachidonic acid epoxygenase) (CYPIIC23),Cyp2c23 Cyp2c-23,Rattus norvegicus (Rat),arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid biosynthetic process [GO:0046456]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to testosterone [GO:0033574]; xenobiotic metabolic process [GO:0006805],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid biosynthetic process [GO:0046456]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to testosterone [GO:0033574]; xenobiotic metabolic process [GO:0006805]",GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0019369; GO:0019373; GO:0020037; GO:0033574; GO:0042738; GO:0043231; GO:0046456; GO:0055114
O61491,FLOT1_DROME,reviewed,Flotillin-1,Flo1 Flo Flo-1 FLODM-1 CG8200,Drosophila melanogaster (Fruit fly),multicellular organism development [GO:0007275]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of endocytosis [GO:0045807]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; regulation of receptor internalization [GO:0002090],GO:0002090; GO:0005198; GO:0005737; GO:0005886; GO:0007275; GO:0016600; GO:0031410; GO:0045807; GO:0070528; GO:0072659; GO:1901890; GO:2000049
Q8R508,FAT3_RAT,reviewed,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Fat3,Rattus norvegicus (Rat),cell-cell adhesion [GO:0098609]; cell morphogenesis involved in differentiation [GO:0000904]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; retina layer formation [GO:0010842],dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; retina layer formation [GO:0010842],GO:0000904; GO:0001764; GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016021; GO:0030425; GO:0098609; GO:2000171
P62997,TRA2B_RAT,reviewed,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",Tra2b Sfrs10,Rattus norvegicus (Rat),"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to reactive oxygen species [GO:0000302]","nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly-purine tract binding [GO:0070717]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to reactive oxygen species [GO:0000302]",GO:0000302; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048025; GO:0048026; GO:0048471; GO:0070717; GO:0071333; GO:1990403
E9PY46,IF140_MOUSE,reviewed,Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2),Ift140 WDTC2,Mus musculus (Mouse),cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589],GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403
O42412,IOD3_CHICK,reviewed,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment),DIO3,Gallus gallus (Chicken),hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403],GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0033798; GO:0042403; GO:0042446
Q7ZVK3,SIR2_DANRE,reviewed,NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),sirt2 zgc:77003,Danio rerio (Zebrafish) (Brachydanio rerio),cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042],centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042],GO:0000122; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006476; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0016525; GO:0016740; GO:0017136; GO:0030496; GO:0032436; GO:0033010; GO:0033270; GO:0034599; GO:0034979; GO:0042177; GO:0042903; GO:0043204; GO:0043209; GO:0043220; GO:0043388; GO:0044224; GO:0045944; GO:0046970; GO:0048471; GO:0051726; GO:0060271; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070933; GO:0071456; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:2000378; GO:2000777
Q80T85,DCAF5_MOUSE,reviewed,DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22),Dcaf5 Kiaa1824 Wdr22,Mus musculus (Mouse),protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein ubiquitination [GO:0016567],GO:0005737; GO:0005739; GO:0016567; GO:0080008
V5NAL9,TLR4_PINIB,reviewed,Toll-like receptor 4 (EC 3.2.2.6) (PmTLR4),,Pinctada imbricata (Atlantic pearl-oyster) (Pinctada martensii),innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]",GO:0002224; GO:0004888; GO:0005886; GO:0016021; GO:0045087; GO:0050135; GO:0061809
E9QAM5,HELZ2_MOUSE,reviewed,Helicase with zinc finger domain 2 (EC 3.6.4.-) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1),Helz2,Mus musculus (Mouse),"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]",GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0030374; GO:0045944; GO:0046872
Q4ZJM9,C1QL4_MOUSE,reviewed,Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11),C1ql4 C1qtnf11 Ctrp11,Mus musculus (Mouse),negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373
Q95NT6,MTH2_DROYA,reviewed,G-protein coupled receptor Mth2 (Protein methuselah-2),mth2,Drosophila yakuba (Fruit fly),cell surface receptor signaling pathway [GO:0007166],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166],GO:0004930; GO:0005886; GO:0007166; GO:0016021
Q61805,LBP_MOUSE,reviewed,Lipopolysaccharide-binding protein (LBP),Lbp,Mus musculus (Mouse),"acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lipopolysaccharide transport [GO:0015920]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496]","cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496]",GO:0001530; GO:0002232; GO:0002281; GO:0005102; GO:0005615; GO:0006953; GO:0008228; GO:0009986; GO:0015920; GO:0016020; GO:0031663; GO:0032490; GO:0032496; GO:0032720; GO:0032722; GO:0032755; GO:0032757; GO:0032760; GO:0033036; GO:0034145; GO:0043032; GO:0045087; GO:0045919; GO:0050829; GO:0050830; GO:0060100; GO:0060265; GO:0070891; GO:0071222; GO:0071223; GO:0071723; GO:0090023; GO:0090559
Q08BB2,P2012_DANRE,reviewed,N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1.2),pm20d1.2 zgc:154035,Danio rerio (Zebrafish) (Brachydanio rerio),adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; nitrogen compound metabolic process [GO:0006807]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]; respiratory electron transport chain [GO:0022904],"extracellular space [GO:0005615]; aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; nitrogen compound metabolic process [GO:0006807]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]; respiratory electron transport chain [GO:0022904]",GO:0004046; GO:0004181; GO:0005615; GO:0006520; GO:0006631; GO:0006807; GO:0016811; GO:0016829; GO:0022904; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0097009; GO:1990845; GO:2000275
Q6KEQ9,PC11X_PIG,reviewed,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X),PCDH11X PCDH11 PCDHX,Sus scrofa (Pig),cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0010923
Q24524,SING_DROME,reviewed,Protein singed,sn CG1536,Drosophila melanogaster (Fruit fly),actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060],GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017
Q04721,NOTC2_HUMAN,reviewed,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],NOTCH2,Homo sapiens (Human),animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060],cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 production [GO:0032633]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]; wound healing [GO:0042060],GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006367; GO:0006915; GO:0006959; GO:0007050; GO:0007219; GO:0007275; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019827; GO:0019899; GO:0030097; GO:0030326; GO:0030513; GO:0032633; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204
Q8N264,RHG24_HUMAN,reviewed,Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP),ARHGAP24 FILGAP,Homo sapiens (Human),"activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]","adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]",GO:0001525; GO:0005096; GO:0005829; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0051056; GO:0090630; GO:1900028
A8Y1P7,BRE4_CAEBR,reviewed,"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)",bre-4 CBG22165,Caenorhabditis briggsae,carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636],"integral component of membrane [GO:0016021]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]",GO:0005975; GO:0006486; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872